Hologic Inc
NASDAQ:HOLX
Hologic Inc
Revenue
Hologic Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hologic Inc
NASDAQ:HOLX
|
Revenue
$4B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Hologic Inc
Revenue Breakdown
Breakdown by Geography
Hologic Inc
Total Revenue:
4B
USD
|
United States:
3.1B
USD
|
International:
972.4m
USD
|
Europe:
520.3m
USD
|
Asia-Pacific:
255.7m
USD
|
Rest Of World:
196.4m
USD
|
Breakdown by Segments
Hologic Inc
Total Revenue:
4B
USD
|
Consumables:
2.5B
USD
|
Diagnostics:
1.9B
USD
|
Breast Health:
1.4B
USD
|
Molecular Diagnostics:
1.4B
USD
|
Breast Imaging:
1.1B
USD
|
Capital Equipment, Components And Software:
740.5m
USD
|
Service:
730.5m
USD
|
Gyn Surgical:
604.2m
USD
|
Cytology & Perinatal:
480.6m
USD
|
Interventional Breast Solutions:
288.5m
USD
|
Skeletal Health:
113.4m
USD
|
Blood Screening:
37.8m
USD
|
Other:
20m
USD
|
See Also
What is Hologic Inc's Revenue?
Revenue
4B
USD
Based on the financial report for Dec 30, 2023, Hologic Inc's Revenue amounts to 4B USD.
What is Hologic Inc's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was -11%. The average annual Revenue growth rates for Hologic Inc have been -4% over the past three years , 4% over the past five years , and 5% over the past ten years .